Skip to main content
Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
1.793
+0.072 (4.17%)
Apr 25, 2025, 4:00 PM EDT - Market closed

Immuron Revenue

Immuron had revenue of 3.99M AUD in the half year ending December 31, 2024, with 584.38% growth. This brings the company's revenue in the last twelve months to 6.54M, up 82.90% year-over-year. In the fiscal year ending June 30, 2024, Immuron had annual revenue of 4.90M with 171.67% growth.

Revenue (ttm)
6.54M AUD
Revenue Growth
+82.90%
P/S Ratio
2.40
Revenue / Employee
934,518 AUD
Employees
7
Market Cap
9.72M USD

Revenue Chart

* This company reports financials in AUD.

History

Fiscal Year End Revenue Change Growth
Jun 30, 20244.90M3.10M171.67%
Jun 30, 20231.80M1.04M135.85%
Jun 30, 2022765.19K619.42K424.91%
Jun 30, 2021145.78K-2.37M-94.21%
Jun 30, 20202.52M131.14K5.49%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.90B
Revenue Rankings

IMRN News

More News